The neuropeptide vasoactive intestinal peptide generates tolerogenic dendritic cells.
about
Binding immunoglobulin protein-treated peripheral blood monocyte-derived dendritic cells are refractory to maturation and induce regulatory T-cell developmentImmunity and Tolerance Induced by Intestinal Mucosal Dendritic CellsThe Neuromodulation of the Intestinal Immune System and Its Relevance in Inflammatory Bowel DiseaseThe neuropeptide vasoactive intestinal peptide: direct effects on immune cells and involvement in inflammatory and autoimmune diseasesRegulatory dendritic cells for immunotherapy in immunologic diseasesPituitary adenylate cyclase-activating polypeptide ameliorates experimental acute ileitis and extra-intestinal sequelaeImmune heterogeneity in neuroinflammation: dendritic cells in the brainSuppression of FVIII inhibitor formation in hemophilic mice by delivery of transgene modified apoptotic fibroblasts.Intestinal bacteria condition dendritic cells to promote IgA productionDendritic cells transduced with lentiviral vectors expressing VIP differentiate into VIP-secreting tolerogenic-like DCs.Vasoactive intestinal peptide: a neuropeptide with pleiotropic immune functions.How tolerogenic dendritic cells induce regulatory T cellsPituitary adenylate cyclase activating peptide deficient mice exhibit impaired thymic and extrathymic regulatory T cell proliferation during EAEVPAC2 (vasoactive intestinal peptide receptor type 2) receptor deficient mice develop exacerbated experimental autoimmune encephalomyelitis with increased Th1/Th17 and reduced Th2/Treg responses.Neural networks in intestinal immunoregulationTherapeutic effect of vasoactive intestinal peptide on experimental autoimmune encephalomyelitis: down-regulation of inflammatory and autoimmune responses.Absence of vasoactive intestinal peptide expression in hematopoietic cells enhances Th1 polarization and antiviral immunity in miceSuppression of the immune response to FVIII in hemophilia A mice by transgene modified tolerogenic dendritic cellsTargeting VIP and PACAP receptor signalling: new therapeutic strategies in multiple sclerosis.VIP Regulates the Development & Proliferation of Treg in vivo in spleenVasoactive intestinal peptide induces regulatory dendritic cells that prevent acute graft-versus-host disease while maintaining the graft-versus-tumor response.Ocular and systemic bio-distribution of rhodamine-conjugated liposomes loaded with VIP injected into the vitreous of Lewis rats.Higher susceptibility to experimental autoimmune encephalomyelitis in Muc1-deficient mice is associated with increased Th1/Th17 responses.Pharmacological inhibition of VIP signaling enhances antiviral immunity and improves survival in murine cytomegalovirus-infected allogeneic bone marrow transplant recipients.Lutzomyia longipalpis salivary peptide maxadilan alters murine dendritic cell expression of CD80/86, CCR7, and cytokine secretion and reprograms dendritic cell-mediated cytokine release from cultures containing allogeneic T cellsTuning immune tolerance with vasoactive intestinal peptide: a new therapeutic approach for immune disordersPlasmodium infection and endotoxic shock induce the expansion of regulatory dendritic cells.Emerging roles of vasoactive intestinal peptide: a new approach for autoimmune therapy.A novel mechanism for immunosuppression: from neuropeptides to regulatory T cells.Pituitary adenylyl cyclase-activating polypeptide is an intrinsic regulator of Treg abundance and protects against experimental autoimmune encephalomyelitis.Endogenous anti-inflammatory neuropeptides and pro-resolving lipid mediators: a new therapeutic approach for immune disorders.The role of CD40 and CD154/CD40L in dendritic cells.Vaccines as early therapeutic interventions for cancer therapy: neutralising the immunosuppressive tumour environment and increasing T cell avidity may lead to improved responses.Treating arthritis by immunomodulation: is there a role for regulatory T cells?Host-bacteria interactions in the intestine: homeostasis to chronic inflammation.Neuropeptides as pleiotropic modulators of the immune response.Cyclic AMP: a selective modulator of NF-κB action.Self-antigen presentation by dendritic cells in autoimmunity.Neuropeptide substance P and the immune response.In situ proximity of CX3CR1-positive mononuclear phagocytes and VIP-ergic nerve fibers suggests VIP-ergic immunomodulation in the mouse ileum.
P2860
Q24648682-2F5060B9-B27B-402C-B378-CB946946355BQ26749134-B43ACEA1-3DF7-45E4-8540-EE7F83A45B93Q26774660-8BF78000-D406-415A-AE63-4A2DC901C426Q26851670-50BF0981-3EAF-42C8-83E4-072D65451E94Q26866216-4791683C-9512-4CCB-AABF-021FF231C8FDQ27345033-8B6912F7-92BA-457B-80BD-093C0F4E65ABQ28385127-4FB5F801-11B6-4DD4-8EB8-B8D5BEF7DE5FQ30493686-A5407E0A-575C-4C38-BE79-5E6EB1C12D86Q33348616-95A87B7F-564B-4B50-92D6-752D758313F6Q33931602-C161EA5C-1C1E-45FE-AD29-5A85CCF830E2Q34238010-6194DA70-1C8C-4F1A-B786-84E8D2054A8AQ34631825-AD499518-26AC-4527-9F20-9A1098E2DA3FQ34684150-4539C3EA-933E-4DE2-ABCF-26FE84E02457Q34765538-C0F7393E-6E74-47EC-BDED-40900963AECDQ34836430-DCF38786-27C1-4606-BEC3-93C8C1956DBFQ35088106-EAD55572-E89C-4002-B245-9A15DFE8B141Q35094493-11C38CA9-4A38-4093-8D0F-F31683211D79Q35285735-52DF8C77-BC75-4B73-BFB5-04737ABE2C81Q35295564-1D54E312-A394-4991-A876-4A63E3DCA02EQ35777156-40A1E281-CCD8-47E1-9ADE-CDB7CC3212E0Q35849658-4A3AD8C2-7E64-403C-A59D-7DBF72841E3DQ36498879-79AE7DB1-FA41-4DE4-861D-57FBC4CA2248Q36653456-98D7327D-B0D9-4583-9CB1-96200C1FD24AQ36709854-DE7A4045-E743-4519-985C-CBE3B4B11218Q36712427-EC409DF6-DC17-4673-9EFB-B46B180CD6F0Q36830470-A517A74D-8C8E-4008-B345-E5C7DD13478BQ36920484-BFEEA6A3-4031-44AE-87C1-1BB1A34CF8BFQ36969911-DBABD427-BA05-4E13-B6E6-3D96F9BEC776Q37015446-FED6EC08-2BFB-48D9-8E25-744C2E180E07Q37100959-EED32432-A0DB-4EA6-8361-1E99FDE02A33Q37191369-1ABFEFEE-D2BC-458D-B390-932F3BC7ACB6Q37518524-64E51EE5-314C-4BEE-A0F9-39AD6848EE29Q37729146-F67D3050-4E21-40DC-BDCD-86635939700CQ37750140-2FF72D62-FE18-4995-8DB0-BD9080EE6C8CQ37787980-FAA9159E-1BCC-4B6B-B631-47B5FF1105BFQ37898396-458F388C-0CCD-45CA-A256-A70037D5735AQ37899788-11C1B9CE-6626-407F-A126-C938BF875108Q38193091-E20A9901-41C1-4EE9-87F7-9CE71C8A89FEQ38868323-48229AEA-8FCB-4D93-AB54-20435045C8DDQ38965340-74E98EB1-859F-482A-8036-6E272ED75950
P2860
The neuropeptide vasoactive intestinal peptide generates tolerogenic dendritic cells.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
The neuropeptide vasoactive intestinal peptide generates tolerogenic dendritic cells.
@en
The neuropeptide vasoactive intestinal peptide generates tolerogenic dendritic cells.
@nl
type
label
The neuropeptide vasoactive intestinal peptide generates tolerogenic dendritic cells.
@en
The neuropeptide vasoactive intestinal peptide generates tolerogenic dendritic cells.
@nl
prefLabel
The neuropeptide vasoactive intestinal peptide generates tolerogenic dendritic cells.
@en
The neuropeptide vasoactive intestinal peptide generates tolerogenic dendritic cells.
@nl
P2093
P1476
The neuropeptide vasoactive intestinal peptide generates tolerogenic dendritic cells.
@en
P2093
Doina Ganea
Elena Gonzalez-Rey
Mario Delgado
P304
P356
10.4049/JIMMUNOL.175.11.7311
P407
P577
2005-12-01T00:00:00Z